Board appointment at Watson Pharmaceuticals
This article was originally published in Scrip
Watson Pharmaceuticals (US) has elected Christopher Bodine to its board of directors. The appointment brings the total number of board members to 10. Mr Bodine retired from CVS Caremark in January after 24 years with the company.